Based on Auxly’s latest financials — now doing roughly $40M/quarter in revenue , running mid-50s gross margins and having turned the corner to consistent, positive EBITDA and net income , a bullish-but-reasonable 12-month price target for XLY lands around $0.30–$0.35. That range assumes Auxly can (1) hold or slightly grow revenue into the $165–$175M annual run-rate, (2) keep EBITDA margins in the high-20s/low-30s, and (3) be rewarded with a modestly re-rated multiple as one of the few profitable, scaled Canadian LPs. At today’s ~$0.155–0.17, that implies roughly a 2x move over the next year — not a moonshot, but a sensible rerating as the market digests that Q3 wasn’t a one-off, balance-sheet risk continues to fall, and more institutions/ETFs are finally willing to touch a profitable, cash-flowing Auxly.Read more
Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. The company offers cannabis products under various forms, including milled and dried flowers, vape cartridges, infused pre-rolls, pre-rolled, all- in-one vapes, edibles, concentrates, oils, and softgels under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. Auxly Cannabis Group Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.
